Presentation



Download 13.8 Kb.
View original pdf
Date26.10.2018
Size13.8 Kb.


The State Commission for the Protection of Economic
Competition of the Republic of Armenia
General competition issues in parallel import of drugs
Manuk Mikayelyan,
Head of Department
Velikiy Novgorod,
September 2017


In 2017 The Commission received a statement from economic entities involved in the import and distribution
of medicinal products on the territory of the Republic of Armenia.
According to the position of economic entities - the Ministry of Health (Ministry) refused to allow certain
medicines to be imported into the Republic of Armenia, which helped to restrict competition in the
pharmaceutical market.
2
According to the position of the Ministry - the aforementioned refusals are due to the fact that some differences
were detected between registered and imported medicines, so they were considered unregistered.
As a result of the Commission's studies conducted in 2013-2015, a number of provisions restricting competition
have been identified in legal acts regulating the import and registration of medicines.
To solve the identified problems, the Commission provided relevant information to the Government of Armenia,
proposing amendments to these acts, finalizing and introducing a full-fledged procedure for parallel importation
of medicines.
As a result, the new drug law, adopted in 2016, finalized and introduced the parallel import procedure.
Currently, there are problems with the full operation of the parallel import system, as existing legal regulations
require that imported and registered drugs are identical, while pharmaceutical companies provide the same
drug to different countries with some differences.


Producer of the drug Merck KGaA (Germany).
Form issued in the Republic of Armenia (2 × 25, 2 blisters with 25 tablets each).
The form of release of the imported preparation (5 × 10, 5 blisters with 10 tablets each).
As a result of the study, it was found out before March 27, 2017 that the drug was registered in the Republic of
Armenia with a package of 5 × 10, and then the above change was made
3
Registered drug
Imported drug
Price
difference

30%


Производитель лекарства Medana Pharma (Польша).
В Армении препарат был зарегистрирован под торговым наименованием Аквадетрим витамин Медана.
4
Registered drug
Imported drug
Price
difference

71%


Manufacturer; Polpharma (Poland).
5
Registered drug
Imported drug
Price
difference

206%


Manufacturer: Berlin-Chemie AG (Germany).
6
Registered drug
Imported drug
Price
difference

88%

Thank you!
5b Mher Mkrtchyan St, Yerevan, Armenia
Tel: (+37410) Fax (+37410) 543-985 Email info@competition.am http://www.competition.am



Share with your friends:


The database is protected by copyright ©userg.info 2017
send message

    Main page

bosch
camera
chevrolet
epson
fiat
Honda
iphone
mitsubishi
nissan
Panasonic
Sony
volvo
xiaomi
yamaha